OFG
ABBV icon

Oxford Financial Group’s AbbVie ABBV Stock Holding History

Oxford Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
4,717
-480
-9% -$106K 0.06% 99
2025
Q4 		$1.19M Buy
5,197
+77
+2% +$17.5K 0.07% 78
2025
Q3 		$1.19M Buy
5,120
+299
+6% +$60.9K 0.07% 81
2025
Q2 		$895K Sell
4,821
-645
-12% -$120K 0.05% 90
2025
Q1 		$1.15M Sell
5,466
-384
-7% -$74.7K 0.08% 72
2024
Q4 		$1.04M Sell
5,850
-62
-1% -$11.4K 0.07% 93
2024
Q3 		$1.17M Sell
5,912
-1,003
-15% -$187K 0.07% 82
2024
Q2 		$1.19M Buy
6,915
+1,317
+24% +$218K 0.08% 81
2024
Q1 		$1.02M Buy
5,598
+176
+3% +$30.3K 0.07% 80
2023
Q4 		$840K Buy
5,422
+175
+3% +$25.5K 0.06% 96
2023
Q3 		$782K Sell
5,247
-298
-5% -$43.7K 0.07% 93
2023
Q2 		$747K Buy
5,545
+2,669
+93% +$391K 0.07% 96
2023
Q1 		$458K Buy
2,876
+204
+8% +$31.2K 0.05% 119
2022
Q4 		$432K Buy
+2,672
New +$410K 0.05% 124
2022
Q3 		– Sell
-2,505
Closed -$384K – 240
2022
Q2 		$384K Buy
2,505
+96
+4% +$14.7K 0.06% 127
2022
Q1 		$391K Sell
2,409
-31
-1% -$4.5K 0.05% 133
2021
Q4 		$330K Buy
2,440
+179
+8% +$21.1K 0.04% 156
2021
Q3 		$244K Sell
2,261
-1,946
-46% -$222K 0.03% 163
2021
Q2 		$474K Sell
4,207
-910
-18% -$102K 0.06% 114
2021
Q1 		$554K Sell
5,117
-168
-3% -$18K 0.08% 102
2020
Q4 		$566K Buy
5,285
+153
+3% +$14.7K 0.08% 94
2020
Q3 		$450K Buy
5,132
+25
+0.5% +$2.35K 0.07% 97
2020
Q2 		$501K Sell
5,107
-13
-0.3% -$1.15K 0.09% 95
2020
Q1 		$390K Buy
+5,120
New +$436K 0.08% 100

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oxford Financial Group's ABBV Position: Q1 2026 in Review

Oxford Financial Group reduced its AbbVie (ABBV) stake by 9.2% in Q1 2026, selling an estimated $106K and leaving 4,717 shares worth $1.03M. The position accounts for 0.06% of the portfolio, ranked #99.

Oxford Financial Group first reported a position in ABBV in Q1 2020 and has held it in 24 quarters since. The position peaked at $1.19M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Oxford Financial Group held 4,717 shares of AbbVie worth $1.03M as of Q1 2026.
  • Oxford Financial Group sold 480 AbbVie shares in Q1 2026, an estimated $106K.
  • AbbVie made up 0.06% of Oxford Financial Group's portfolio in Q1 2026, its #99 holding.
  • Oxford Financial Group first reported a position in AbbVie in Q1 2020 and has held it in 24 quarters since.
  • Oxford Financial Group's AbbVie position peaked at $1.19M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Oxford Financial Group's 13F filing for Q1 2026, filed 6 May 2026.